Financial Data and Key Metrics Changes - The company reported a total revenue of approximately $6.1 billion, with 77% of sales coming from the U.S. and 18% from international markets [3][4] - The company aims for a steady stream of 4% organic volume growth, with specific targets of 3% for U.S. domestic, 8% for international, and 5% for the SPD business [52][54] - The company has achieved an average of over 4% growth over the past decade, with a focus on margin expansion of 25 to 50 basis points annually [54][56] Business Line Data and Key Metrics Changes - The Fabric Care business saw a growth rate of 1.4% in Q2, with ARM and HAMMER outpacing the category [12] - The Cat Litter category started at 2% growth and accelerated to 4%, with a year-to-date share growth [15] - The Hero Agne category maintained double-digit growth, increasing its market share from 1% in 2020 to 22% [20] - TheraBreath achieved a market share increase from 4% to 21% over five years, becoming the number two mouthwash brand [25] Market Data and Key Metrics Changes - International sales account for 18% of total sales, with a growth rate of 5.8% in the first half of the year [43] - The company has expanded its global footprint, with TheraBreath being the number one mouthwash in key retailers across several countries [36] - The e-commerce segment has grown significantly, now accounting for 23% of total sales, with five of the eight power brands increasing their online share [34][35] Company Strategy and Development Direction - The company is focused on innovation as a key growth driver, with half of its 4% growth in 2024 attributed to new product launches [37] - The acquisition of TouchLand is seen as a strategic move to enhance the company's portfolio, targeting the hand sanitizer market [30][32] - The company is committed to maintaining a balanced portfolio, with a focus on both premium and value segments [4][5] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's future despite a volatile environment, emphasizing a balanced portfolio and share gains across brands [2][4] - The outlook for 2025 includes expectations of 0% to 2% organic sales growth and adjusted EPS growth of 0% to 2% [58] - Management highlighted the importance of managing tariffs and reducing exposure from $190 million to $50 million [61] Other Important Information - The company has a strong cash position with over $5 billion available for investments, including M&A opportunities [63] - The company is actively reviewing its brands and may divest underperforming segments to enhance shareholder value [60] Q&A Session Summary Question: Clarification on second quarter consumption expectations - Management confirmed that global organic growth was around 2.5%, with categories performing slightly better than expected [67][68] Question: Inquiry about M&A strategy and investment hurdles - Management stated that they are selective in M&A, focusing on long-term brand viability and typically aiming for around a 10x EBITDA multiple for acquisitions [71][73]

Financial Data and Key Metrics Changes - Church & Dwight reported a company size of approximately $6.1 billion, with 77% of sales in the U.S. and 18% internationally [3][4] - The company aims for 4% organic volume growth, with specific targets of 3% for U.S. domestic, 8% for international, and 5% for the SPD business [57][58] - The EPS growth outlook for 2025 is projected at 0% to 2%, with expectations of 2.5% organic growth in the second half of the year [63][64] Business Line Data and Key Metrics Changes - The Fabric Care business saw a growth rate of 1.4% in Q2, with ARM and HAMMER outpacing the category [13] - Cat litter performance improved from 2% to 4% growth, with a year-to-date share growth [16] - The Hero Agne category maintained double-digit growth, increasing its market share from 1% in 2020 to 22% [21] - TheraBreath achieved significant growth, becoming the number two mouthwash brand with a share increase from 4% to 21% over five years [25] Market Data and Key Metrics Changes - International sales account for 18% of total sales, with a growth rate of 5.8% in the first half of the year [47] - The e-commerce segment has grown significantly, now representing 23% of total sales, up from 22% in 2016 [33] - The company has expanded its global footprint, with TheraBreath being the number one mouthwash in key retailers across multiple countries [35] Company Strategy and Development Direction - The company focuses on a balanced portfolio, with eight power brands contributing to 75% of sales and profits [4] - The Evergreen Model guides the company's strategy, emphasizing consistent growth, margin expansion, and marketing investments [56][60] - Recent acquisitions, including TouchLand, are aimed at enhancing the product portfolio and driving growth [30][32] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's future despite a volatile environment, highlighting share gains across many brands [2][3] - The company remains focused on what it can control, including managing tariffs and investing in innovation [62][67] - The management reiterated confidence in achieving sales growth and maintaining a strong balance sheet with over $5 billion available for investments [69][70] Other Important Information - The company has divested from underperforming brands and is focusing on revitalizing its vitamin business [65][66] - Gross margin pressures from tariffs have been reduced from $190 million to $50 million through action plans [67] Q&A Session Summary Question: Clarification on second quarter consumption expectations - Management clarified that the 2.5% growth is based on global organic growth, with categories performing at expected levels [72][73] Question: Inquiry about M&A interests and return on investment hurdles - Management explained their unique approach to M&A, emphasizing a focus on long-term brand viability and a typical EBITDA multiple target of around 10x [77][79]